These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Indications for, limitations, and hazards of neuroleptic agents]. Hoes MJ Ned Tijdschr Geneeskd; 1980 Apr; 124(17):647-53. PubMed ID: 6104304 [No Abstract] [Full Text] [Related]
43. De novo treatment-resistant psychosis following thioridazine withdrawal. Bastiampillai T; Fantasia R; Nelson A Aust N Z J Psychiatry; 2014 Jun; 48(6):585-6. PubMed ID: 23908310 [No Abstract] [Full Text] [Related]
44. Exacerbation of psychotic symptoms due to benzodiazepine withdrawal. Özdemir O; Atilla E J Neuropsychiatry Clin Neurosci; 2014; 26(3):E23-4. PubMed ID: 25093773 [No Abstract] [Full Text] [Related]
46. Repeated occurrence of clozapine-induced myocarditis in a patient with schizoaffective disorder and comorbid Parkinson's disease. Masopust J; Urban A; Valis M; Malý R; Tůma I; Hosák L Neuro Endocrinol Lett; 2009 Mar; 30(1):19-21. PubMed ID: 19300384 [TBL] [Abstract][Full Text] [Related]
47. [Predicting the success of a benzodiazepine discontinuation programme: myths or clinical wisdom?]. Knoop H; Kan CC; Mickers FC; Barnhoorn D Tijdschr Psychiatr; 2006; 48(9):695-703. PubMed ID: 17007475 [TBL] [Abstract][Full Text] [Related]
49. Antipsychotic withdrawal phenomena in the medical-surgical setting. Dilsaver SC; Coffman JA Gen Hosp Psychiatry; 1988 Nov; 10(6):438-46. PubMed ID: 2904918 [TBL] [Abstract][Full Text] [Related]
50. Tardive priapism associated with clozapine. A case report. Raja M; Azzoni A Pharmacopsychiatry; 2006 Sep; 39(5):199-200. PubMed ID: 16944414 [TBL] [Abstract][Full Text] [Related]
51. Reducing the burden of side effects during long-term antipsychotic therapy: the role of "switching" medications. Weiden PJ; Buckley PF J Clin Psychiatry; 2007; 68 Suppl 6():14-23. PubMed ID: 17650055 [TBL] [Abstract][Full Text] [Related]
52. Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients. Kissling W; Glue P; Medori R; Simpson S Hum Psychopharmacol; 2007 Dec; 22(8):505-13. PubMed ID: 17902187 [TBL] [Abstract][Full Text] [Related]
53. Abstinence, anticipation, reduction, and treatment (AART): a stepwise approach to the management of atypical antipsychotic side effects. Kennedy A; Tapp A; Kelly WS; Kilzieh N; Wood AE Essent Psychopharmacol; 2006; 7(1):1-14. PubMed ID: 16989288 [TBL] [Abstract][Full Text] [Related]
54. Alcohol withdrawal syndrome: how to predict, prevent, diagnose and treat it. Prescrire Int; 2007 Feb; 16(87):24-31. PubMed ID: 17323538 [TBL] [Abstract][Full Text] [Related]
55. Long-term adjunctive quetiapine may reduce substance use--a preliminary retrospective study. Sattar SP; Schultz SK; Arndt S; Soundy T; Petty F S D Med; 2007 Nov; 60(11):437, 439-41, 443 passim. PubMed ID: 18196687 [TBL] [Abstract][Full Text] [Related]
56. [Short- and long-term results of a systematic benzodiazepine discontinuation programme for psychiatric patients]. Kan CC; Mickers FC; Barnhoorn D Tijdschr Psychiatr; 2006; 48(9):683-93. PubMed ID: 17007474 [TBL] [Abstract][Full Text] [Related]
57. Slight improvement in mood and irritability after antiepileptic drug withdrawal: a controlled study in patients on monotherapy. Hessen E; Lossius MI; Reinvang I; Gjerstad L Epilepsy Behav; 2007 May; 10(3):449-55. PubMed ID: 17350342 [TBL] [Abstract][Full Text] [Related]
58. Neurological complications of psychiatric drugs: clinical features and management. Haddad PM; Dursun SM Hum Psychopharmacol; 2008 Jan; 23 Suppl 1():15-26. PubMed ID: 18098217 [TBL] [Abstract][Full Text] [Related]